Biogen (BIIB)

EBITDA Margin

19.66%

TTM · Period ending:

BIIB logo

BIIB EBITDA Margin

Latest reported19.66%
BIIB TTM EBITDA Margin (-310.26% → 19.66%)
High-resolution chart · PNG

BIIB ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Biogen EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
38.4391%
39.1125%
39.6329%
44.8839%
48.6103%
49.5583%
49.3841%
47.5266%
46.5641%
45.2742%
45.1999%
45.945%
45.6416%
46.1957%
45.0897%
37.0343%
39.3253%
32.9373%
28.3174%
26.5913%
12.0308%
17.8862%
21.9927%
17.4144%
0.322%
-0.0365%
6.5542%
-13.4043%
10.3424%
18.5517%
19.7359%
38.27%
37.6756%
33.5%
28.479%
9.6%
-2.3292%
1.9481%
6.3518%
10.7023%
11.8261%
10.1476%
8.7824%
-0.6849%
-8.094%
11.1446%
36.2712%
-50.7246%
-34.2975%
-40.6926%
-57.767%
-95.2381%
-118.6667%
-200.9174%
-285.8824%
-373.3333%
-454.6875%
-429.8507%
-463.4921%
-471.4286%
-310.2564%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.